Clinical Trial Update: Ponatinib Plus Chemotherapy in Acute Lymphoblastic Leukemia Patients [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating ponatinib in combination with chemotherapy for acute lymphoblastic leukemia; currently not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia

Drugs mentioned

• Ponatinib (ponatinib)

Snippet

Sponsor: Gruppo Italiano Malattie EMatologiche dell'Adulto | Conditions: Chemotherapy, Leukemia, Acute Lymphoblastic | Phase 2 | Status: ACTIVE_NOT_RECRUITING